oxazoles has been researched along with Adjuvant Arthritis in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (37.50) | 18.7374 |
| 1990's | 5 (20.83) | 18.2507 |
| 2000's | 8 (33.33) | 29.6817 |
| 2010's | 2 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bevaart, L; Clark, R; Elbaum, D; Koepke, J; Koopman, FA; Lamppu, D; LaRosa, GJ; Papke, RL; Tak, PP; van Maanen, MA; Vervoordeldonk, MJ | 1 |
| Gyires, K; Mátyus, P; Mérey, A; Szökő, E; Tábi, T; Tóth, V | 1 |
| Bullington, JL; Jackson, PF | 1 |
| Albert, LM; Frail, DE; Harris, HA; Henderson, RA; Keith, JC; Kharode, YP; Komm, BS; Leathurby, Y; Malamas, MS; Marzolf, J; Mewshaw, RE; Miller, CP; Winneker, RC; Zhu, Y | 1 |
| Blum, E; Buhl, T; Di Padova, FE; Feifel, R; Gram, H; Hiestand, P; Manning, U; Revesz, L; Rucklin, G | 1 |
| Gardner, CR; Seed, MP | 1 |
| Chelsky, D; Dorner, AJ; Follettie, MT; Harris, HA; Hayward, C; Kearney, P; Keith, JC; Paramithiotis, E; Pinard, M; Thibault, P; Wang, L | 1 |
| Al Abed, Y; Claesson, M; Cuzzocrea, S; Donia, M; Kim, J; Mangano, K; Mazzon, E; Miljkovic, D; Nicoletti, F; Stojanovic, I; Stosic-Grujicic, S; Wang, M | 1 |
| Buescher, HH; Hill, RC; Maurer, R; Roemer, D | 1 |
| Masaki, M; Matsushita, M; Tanaka, T; Wakitani, K; Yagi, Y | 1 |
| Masaki, M; Matsushita, M; Wakitani, K | 1 |
| Beleta, J; Cardelús, I; Crespo, MI; Feixas, J; Godessart, N; Heredia, A; Huerta, JM; Ibarzo, J; Jiménez, JM; López, M; Miralpeix, M; Palacios, JM; Puig, C; Puig, J; Ryder, H; Segarra, V; Soca, L | 1 |
| Barrish, JC; Bednarz, MS; Berry, KK; Chen, BC; Cheney, DL; Dhar, TG; Fleener, CA; Gu, HH; Guo, J; Harper, TW; Hollenbaugh, DL; Iwanowicz, EJ; Liu, C; MacMaster, JF; McIntyre, KW; Miller, LM; Pitts, WJ; Rouleau, KA; Shen, Z; Sherbina, NZ; Shuster, DJ; Tredup, JA; Watterson, SH; Witmer, MR; Zhao, R | 1 |
| Diamantis, W; Ludwig, BJ; Sofia, RD | 1 |
| DiPasquale, G; Gingold, J; Rassaert, C; Schwartz, E; Welaj, P | 1 |
| Dove, PA; Rosenthale, ME; Sandor, A; Shriver, DA; White, CB | 1 |
| DiPasquale, G; Rassaert, C; Tripp, L; Welaj, P | 1 |
| DiPasquale, G; Gingold, J; Rassaert, C; Richter, R; Singer, R; Welaj, P | 1 |
| Barber, WE; Bloxham, DP; Bradshaw, D; Cashin, CH; Machin, PJ; Osbond, JM; Self, CR; Smithen, CE; Tong, BP; Wickens, JC | 1 |
| Miyake, H; Ono, N; Sunami, A; Yamamoto, N; Yamasaki, Y | 1 |
| Bloxham, DP; Bradshaw, D; Cashin, CH; Dodge, BB; Lewis, EJ; Self, CR; Westmacott, D | 1 |
| Hirschelmann, R; Schade, R | 1 |
| Buyniski, JP; Gylys, JA; Pasternak, RD; Siminoff, P; Wadopian, NS; Wright, RN | 1 |
| Bartlett, RR; Schleyerbach, R | 1 |
1 review(s) available for oxazoles and Adjuvant Arthritis
| Article | Year |
|---|---|
Pyridinylimidazole based p38 MAP kinase inhibitors.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Drug Design; Enzyme Inhibitors; Humans; Imidazoles; Indoles; Mitogen-Activated Protein Kinases; Oxazoles; p38 Mitogen-Activated Protein Kinases; Pyridines; Structure-Activity Relationship; Thiazoles; Tumor Cells, Cultured | 2002 |
23 other study(ies) available for oxazoles and Adjuvant Arthritis
| Article | Year |
|---|---|
Two novel α7 nicotinic acetylcholine receptor ligands: in vitro properties and their efficacy in collagen-induced arthritis in mice.
Topics: Acetylcholine; alpha7 Nicotinic Acetylcholine Receptor; Anilides; Animals; Arthritis, Experimental; Cell Line; Inflammation; Knee Joint; Ligands; Mice; Mice, Inbred Strains; Oxazoles; PC12 Cells; Piperazines; Pyridines; Rats; Signal Transduction; Xenopus | 2015 |
Study on SSAO enzyme activity and anti-inflammatory effect of SSAO inhibitors in animal model of inflammation.
Topics: Amine Oxidase (Copper-Containing); Animals; Arthritis, Experimental; Carrageenan; Disease Models, Animal; Enzyme Inhibitors; Functional Laterality; Gene Expression Regulation, Enzymologic; Hydrazines; Inflammation; Male; Oxazoles; Oximes; Rats; Rats, Wistar; Time Factors | 2013 |
Evaluation of an estrogen receptor-beta agonist in animal models of human disease.
Topics: Animals; Animals, Genetically Modified; Arthritis, Experimental; beta 2-Microglobulin; Bone Density; Bone Diseases, Metabolic; Cell Line; Disease Models, Animal; Estrogen Receptor beta; Female; HLA-B27 Antigen; Humans; Inflammatory Bowel Diseases; Mammary Glands, Animal; Mice; Ovariectomy; Oxazoles; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Receptors, Estrogen; Uterus; Weight Gain | 2003 |
Novel p38 inhibitors with potent oral efficacy in several models of rheumatoid arthritis.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Collagen; Disease Models, Animal; Enzyme Inhibitors; Imidazoles; Lipopolysaccharides; Mice; Oxazoles; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Structure-Activity Relationship; Thiazoles; Tumor Necrosis Factor-alpha | 2004 |
The modulation of intra-articular inflammation, cartilage matrix and bone loss in mono-articular arthritis induced by heat-killed Mycobacterium tuberculosis.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Azathioprine; Cartilage, Articular; Cyclosporine; Dexamethasone; Glycosaminoglycans; Hot Temperature; Immunosuppressive Agents; Injections, Intra-Articular; Levamisole; Lymphocytes; Macrophages; Male; Mycobacterium tuberculosis; Neutrophil Infiltration; Osteoclasts; Osteolysis; Oxazoles; Patella; Prednisolone; Rats; Rats, Wistar; Synovial Membrane | 2005 |
Organ messenger ribonucleic acid and plasma proteome changes in the adjuvant-induced arthritis model: responses to disease induction and therapy with the estrogen receptor-beta selective agonist ERB-041.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Biomarkers; Blood Proteins; Estrogen Receptor beta; Gene Expression Profiling; Liver; Lymph Nodes; Male; Organ Specificity; Oxazoles; Random Allocation; Rats; Rats, Inbred Lew; RNA, Messenger; Spleen | 2006 |
In vitro, ex vivo and in vivo immunopharmacological activities of the isoxazoline compound VGX-1027: modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models.
Topics: Acetates; Acetylmuramyl-Alanyl-Isoglutamine; Animals; Arthritis, Experimental; CD4-Positive T-Lymphocytes; Cell Proliferation; Cell Survival; Cytokines; Female; I-kappa B Proteins; Immunologic Factors; Leukocytes, Mononuclear; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Inbred DBA; Mitogen-Activated Protein Kinases; Oxazoles; Phosphorylation; Pleurisy; Shock, Septic; Spleen; Survival Rate | 2007 |
Analgesic properties of the GABA-mimetic THIP.
Topics: Analgesics; Animals; Arthritis, Experimental; Baclofen; Electric Stimulation; Isoxazoles; Macaca mulatta; Mice; Morphine; Muscimol; Oxazoles; Reaction Time | 1981 |
Pharmacological profile of JTE-522, a novel prostaglandin H synthase-2 inhibitor, in rats.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Benzenesulfonates; Carrageenan; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Hyperalgesia; Indomethacin; Isoenzymes; Male; Membrane Proteins; Oxazoles; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Rats, Wistar | 1997 |
Inhibitory effects of JTE-522, a novel prostaglandin H synthase-2 inhibitor, on adjuvant-induced arthritis and bone changes in rats.
Topics: Administration, Oral; Amino Acids; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Benzenesulfonates; Bone Density; Cyclooxygenase Inhibitors; Hindlimb; Indomethacin; Male; Oxazoles; Pyridinium Compounds; Radiography; Rats; Rats, Inbred Lew; Stomach | 1998 |
Synthesis and biological evaluation of 3,4-diaryloxazolones: A new class of orally active cyclooxygenase-2 inhibitors.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Cyclooxygenase Inhibitors; Fever; Humans; Magnetic Resonance Spectroscopy; Male; Oxazoles; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Structure-Activity Relationship | 2000 |
Discovery of N-[2-[2-[[3-methoxy-4-(5-oxazolyl)phenyl]amino]-5-oxazolyl]phenyl]-N-methyl-4- morpholineacetamide as a novel and potent inhibitor of inosine monophosphate dehydrogenase with excellent in vivo activity.
Topics: Animals; Antibody Formation; Arthritis, Experimental; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; IMP Dehydrogenase; Male; Mice; Mice, Inbred BALB C; Morpholines; Mycophenolic Acid; Oxazoles; Rats; Rats, Inbred Lew; Structure-Activity Relationship | 2002 |
Pharmacological properties of 2,3-dihydro-9H-isoxazolo [3,2-b] quinazolin-9-one (W-2429. Part 1: Analgesic, antipyretic and antiedema activity.
Topics: Administration, Oral; Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Aspirin; Body Temperature; Dextropropoxyphene; Drug Interactions; Drug Tolerance; Edema; Fever; Humans; Injections, Intravenous; Isoxazoles; Lethal Dose 50; Male; Mice; Narcotic Antagonists; Oxazoles; Quinazolines; Rats; Substance-Related Disorders; Time Factors | 1977 |
Effects of multiple treatments of isoxicam on organ weights and serum SGPT, AP, and BUN in adjuvant-induced polyarthritic rats.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Arthritis; Arthritis, Experimental; Blood Urea Nitrogen; Isoxazoles; Male; Organ Size; Oxazoles; Piroxicam; Rats; Thiazines | 1978 |
A profile of the gastrointestinal toxicity of aspirin, indomethacin, oxaprozin, phenylbutazone, and fentiazac in arthritic and Lewis normal rats.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Arthritis; Arthritis, Experimental; Aspirin; Body Weight; Gastrointestinal Diseases; Indomethacin; Intestine, Small; Male; Oxazoles; Phenylbutazone; Propionates; Rats; Stomach; Thiazoles; Time Factors | 1977 |
Anti-inflammatory activity of isoxicam in combination with aspirin or D-propoxyphene.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Aspirin; Body Weight; Dextropropoxyphene; Drug Therapy, Combination; Isoxazoles; Male; Organ Size; Oxazoles; Piroxicam; Rats; Thiazines | 1976 |
The anti=inflammatory properties of isoxicam (4-hydroxy-2methyl-N-(5-methyl-3isoxolyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide).
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Carrageenan; Inflammation; Isoxazoles; Male; Oxazoles; Peptic Ulcer; Piroxicam; Rats; Thiazines | 1975 |
Romazarit: a potential disease-modifying antirheumatic drug.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Chemical Phenomena; Chemistry; Drug Evaluation, Preclinical; Female; Oxazoles; Rats; Structure-Activity Relationship | 1991 |
[Pharmacological profile of mofezolac, a new non-steroidal analgesic anti-inflammatory drug].
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Body Weight; Capillary Permeability; Cyclooxygenase Inhibitors; Edema; Gastric Mucosa; Isoxazoles; Mice; Organ Size; Oxazoles; Platelet Aggregation Inhibitors; Rabbits; Rats | 1990 |
Biologic properties of romazarit (Ro 31-3948), a potential disease-modifying antirheumatic drug.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Experimental; Bone and Bones; Clofibrate; Dinoprostone; Drug Evaluation, Preclinical; Female; Guinea Pigs; Male; Microbial Collagenase; Oxazoles; Rabbits; Rats | 1990 |
6-Sulfanilamidoindazole arthritis in rats: influence of the new anti-inflammatory agent CGP 28237 and of the immunomodulating compound HWA 486 on degree of arthritis and on acute phase reaction.
Topics: Acute-Phase Reaction; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Experimental; Indans; Indenes; Inflammation; Isoxazoles; Leflunomide; Oxazoles; Rats; Sulfanilamides | 1988 |
Disease modifying activity of HWA 486 in rat adjuvant-induced arthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Arthritis, Experimental; Cyclosporins; Hypersensitivity, Delayed; In Vitro Techniques; Isoxazoles; Leflunomide; Lymphocyte Activation; Male; Oxazoles; Rats; Rats, Inbred Lew | 1987 |
Immunopharmacological profile of a novel isoxazol derivative, HWA 486, with potential antirheumatic activity--I. Disease modifying action on adjuvant arthritis of the rat.
Topics: Animals; Anti-Inflammatory Agents; Arthritis; Arthritis, Experimental; Cyclophosphamide; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Activation; Male; Oxazoles; Radiography; Rats; Rats, Inbred Lew | 1985 |